Artificial Intelligence in Healthcare: Coruscant at the Core of a Structuring European Initiative - Coruscant

Fragmentation of healthcare systems, difficulty in scaling from innovation to implementation, deployment, and silos between technologies, data, and clinical use cases: the effective integration of artificial intelligence into care pathways remains a major challenge across Europe.

Supported by the European Commission, the “From Chips to Healthcare Services” initiative specifically aims to address this issue by structuring an integrated healthcare value chain, spanning from critical technologies through to care delivery services.

Within this context, Coruscant, Willing’s applied AI unit, plays a pivotal role by helping bridge technologies, data, regulatory frameworks, and clinical applications.

A European initiative to structure a new healthcare value chain

To date, the various technological building blocks of digital health are still often developed in silos: semiconductors, data infrastructures, artificial intelligence, medical devices, and care services are all evolving along separate trajectories.

This fragmentation limits their operational integration and hinders the scaling up of innovations.

The “From Chips to Healthcare Services” initiative is built on an integrated approach aimed at creating a seamless technological continuum spanning:

semiconductors,
embedded systems and edge computing,
artificial intelligence,
data infrastructures,
and healthcare services delivered to patients.-.

The aim is to connect these different layers to enable seamless use of data and the effective integration of innovations into care pathways.

This approach should make it possible to transform currently isolated technological advances into solutions capable of being deployed at scale across European healthcare systems.

Coruscant: A structuring role within the healthcare component of the Program

In this context, Coruscant is helping to shape the healthcare dimension of the program, alongside major industrial and technology players such as STMicroelectronics, Medtronic, Philips, and Thermo Fisher Scientific.

Its contributions focus mainly on:

The strategic structuring of the healthcare sector,
Contributing to the drafting of the European position paper,
Aligning technologies, clinical use cases, and regulatory frameworks,
Ensuring coherence among industrial, medical, and institutional stakeholders.

This role involves managing multiple levels of complexity simultaneously: technological, organisational and regulatory.

It is not only a matter of integrating artificial intelligence solutions, but of creating the conditions for their adoption and large-scale deployment.

Connecting Technologies, Data, and Clinical Use Cases

One of the project’s key challenges lies in ensuring integration across technological layers that remain largely siloed within healthcare systems.

To enable the effective use of artificial intelligence in patient care pathways, it is necessary to ensure continuity between:

data capture devices (sensors, medical devices),
local processing capabilities (edge computing, embedded AI),
large-scale processing infrastructures (cloud, data platforms),
interoperable environments enabling secure data sharing,
and clinical services integrated into patient care pathways.

For instance, certain architectures now allow critical data from medical devices to be processed locally before being securely transmitted to hospital platforms or shared data infrastructures. These approaches pave the way for more seamless, faster, and better-integrated clinical use cases.

This integration logic goes beyond technological infrastructure alone. It also requires aligning stakeholders that still operate under distinct dynamics: industrial players, digital actors, healthcare providers, and public institutions.

This is precisely where Coruscant contributes, by addressing at the same time:

technical constraints,
medical use cases,
regulatory requirements,
and data governance challenges.

The aim is to create the conditions necessary for the large-scale operational deployment of innovations.

A matter of technological and health sovereignty

The initiative is part of a broader effort to strengthen Europe’s sovereignty in health technologies.

It aligns with several key European frameworks:

the European Chips Act, for the control of critical technologies,
the AI Act, for the regulation of artificial intelligence,
the European Health Data Space, for the organisation and sharing of health data.

The aim is to ensure that solutions developed in Europe:

are compatible with European regulatory frameworks,
meet high ethical standards,
meet the needs of local healthcare systems.

In this context, the challenge is not only technological, but also strategic and political.

Turning innovation into operational impact

Beyond system structuring, the central issue remains impact.

The value of the technologies developed within the initiative ultimately lies in their ability to deliver tangible improvements in how healthcare systems operate.

La valeur des technologies développées dans le cadre du projet se mesure à leur capacité à produire des effets concrets sur le fonctionnement des systèmes de santé.

The work undertaken contributes in particular to:

streamlining care pathways,
reducing diagnostic timelines,
optimizing the use of medical resources,
strengthening prevention capabilities.

Delivering on this transformation requires a pragmatic, use case–driven approach, closely aligned with in-field realities.

The challenge is no longer simply to develop innovative healthcare technologies, but to create the conditions for their widespread adoption in complex, regulated clinical environments.

Going further

The integration of artificial intelligence into the healthcare sector involves fundamental decisions regarding architecture, governance, compliance and the organisation of stakeholders.

Through Coruscant, Willing supports public and private sector organisations with these challenges, from strategic planning to operational deployment.

To find out more, please get in touch with our team.